Takeda Announces Candidates for New Directors

April 13, 2017

Osaka, Japan, April 13, 2017 – Takeda Pharmaceutical Company Limited (TSE 4502) today announced that it has decided the candidates for new Directors which will be proposed to the 141^st Ordinary General Meeting of Shareholders on June, 2017. The candidates are as follows;

1. Candidates for Non-Audit and Supervisory Committee Director

Name	Category		Current Role
Christophe Weber	Internal	Existing	Representative Director, President & Chief Executive Officer
Masato Iwasaki	Internal	Existing	Director, President, Japan Pharma Business Unit
James Kehoe	Internal	New	Corporate Officer, Chief Financial Officer
Andrew Plump	Internal	Existing	Director, Chief Medical & Scientific Officer
Yoshiaki Fujimori	External	Existing	External Director
Emiko Higashi	External	Existing	External Director
Michel Orsinger	External	Existing	External Director
Masahiro Sakane	External	Existing	External Director
Toshiyuki Shiga	External	Existing	External Director

2. Candidates for Audit and Supervisory Committee Directors
Audit and Supervisory Committee Directors (Yasuhiko Yamanaka, Shiro Kuniya, Koji Hatsukawa and Jean-Luc Butel) are within their 2-year tenure, and are not subjects for reelection this year.

3. Directors who will retire

Name	Category	Current Role
Yasuchika Hasegawa	Internal	Director, Chairman of the Board
Shinji Honda	Internal	Director, Corporate Strategy Officer
Fumio Sudo	External	External Director

Yasuchika Hasegawa will be appointed as Corporate Counselor upon the company request after retiring from Chairman of the Board.

While we will not appoint a successor to Chairman Hasegawa on this occasion, Masahiro Sakane, who has been an External Director of Takeda since 2014, has kindly accepted to chair the board meeting after the General Meeting of Shareholders in June.

# # #

Media Contact
Tsuyoshi Tada
Tel: +81-3-3278-2417
Email: [email protected]